M O'Donnell

653 total citations
12 papers, 539 citations indexed

About

M O'Donnell is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, M O'Donnell has authored 12 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Molecular Biology. Recurrent topics in M O'Donnell's work include Lipoproteins and Cardiovascular Health (6 papers), Peripheral Artery Disease Management (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). M O'Donnell is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Peripheral Artery Disease Management (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). M O'Donnell collaborates with scholars based in United Kingdom, United States and Italy. M O'Donnell's co-authors include Mary Seed, Klaus A. Miczek, B. O'Connor, D.A. Reaveley, Mandeep S. Sidhu, David Crook, John C. Stevenson, Edwina A. Brown, Brian L. Knight and P. H. Wise and has published in prestigious journals such as The Lancet, Diabetes and Psychopharmacology.

In The Last Decade

M O'Donnell

12 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M O'Donnell United Kingdom 9 242 179 90 71 66 12 539
Frédéric Chagnon Canada 13 133 0.5× 48 0.3× 63 0.7× 152 2.1× 21 0.3× 25 797
J. M. Thomas United Kingdom 12 127 0.5× 176 1.0× 29 0.3× 32 0.5× 68 1.0× 22 553
Palle Bratholm Denmark 14 46 0.2× 61 0.3× 87 1.0× 38 0.5× 26 0.4× 22 457
Friederike Schulze Switzerland 10 295 1.2× 202 1.1× 110 1.2× 14 0.2× 22 0.3× 13 820
Cristina Grande Spain 16 201 0.8× 221 1.2× 45 0.5× 73 1.0× 9 0.1× 51 726
Patrick Y. Wong Hong Kong 13 66 0.3× 52 0.3× 44 0.5× 65 0.9× 8 0.1× 21 486
Barry Z. Izenstein United States 6 88 0.4× 236 1.3× 41 0.5× 13 0.2× 14 0.2× 8 529
Κ. Schöffling Germany 16 181 0.7× 440 2.5× 92 1.0× 16 0.2× 9 0.1× 133 866
Mark Nixon United Kingdom 14 73 0.3× 187 1.0× 67 0.7× 11 0.2× 20 0.3× 42 741
Piotr Soszyński Poland 14 45 0.2× 399 2.2× 110 1.2× 44 0.6× 12 0.2× 47 738

Countries citing papers authored by M O'Donnell

Since Specialization
Citations

This map shows the geographic impact of M O'Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M O'Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M O'Donnell more than expected).

Fields of papers citing papers by M O'Donnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M O'Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M O'Donnell. The network helps show where M O'Donnell may publish in the future.

Co-authorship network of co-authors of M O'Donnell

This figure shows the co-authorship network connecting the top 25 collaborators of M O'Donnell. A scholar is included among the top collaborators of M O'Donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M O'Donnell. M O'Donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
McGrath, Emer R., Colin A. Espie, Albert Power, et al.. (2016). [OP.4C.06] SLEEP TO LOWER ELEVATED BLOOD PRESSURE. Journal of Hypertension. 34(Supplement 2). e48–e48. 1 indexed citations
2.
Misra, Madhukar, et al.. (1997). The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.. PubMed. 13. 168–73. 3 indexed citations
3.
Reaveley, D.A., et al.. (1995). Lipids and lipoprotein(a) as risk factors for vascular disease in patients on renal replacement therapy. Nephrology Dialysis Transplantation. 10(3). 354–357. 46 indexed citations
4.
Dubrey, Simon W, Mary Seed, David A. Lane, et al.. (1994). Risk Factors for Cardiovascular Disease in IDDM: A Study of Identical Twins. Diabetes. 43(6). 831–835. 47 indexed citations
5.
Seed, Mary, et al.. (1993). Does cyclosporin increase lipoprotein(a) concentrations in renal transplant recipients?. The Lancet. 341(8840). 268–270. 64 indexed citations
6.
Seed, Mary, et al.. (1993). The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover. Atherosclerosis. 101(1). 61–68. 81 indexed citations
7.
Reaveley, D.A., et al.. (1993). Lipoprotein (a) in patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrology Dialysis Transplantation. 8(7). 609–613. 37 indexed citations
8.
Dubrey, Simon W, et al.. (1993). Effect of Insulin-Dependent Diabetes Mellitus on Lipids and Lipoproteins: A Study of Identical Twins. Clinical Science. 84(5). 537–542. 5 indexed citations
9.
Plan, Manuel R., D.A. Reaveley, M O'Donnell, et al.. (1992). Lipid and lipoprotein (a) concentrations in renal ransplant patients. Nephrology Dialysis Transplantation. 7(7). 636–641. 35 indexed citations
10.
Crook, David, Mandeep S. Sidhu, Mary Seed, M O'Donnell, & John C. Stevenson. (1992). Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid. Atherosclerosis. 92(1). 41–47. 89 indexed citations
11.
O'Donnell, M, Michael Nelson, P. H. Wise, & Daniel M. Walker. (1991). A computerized diet questionnaire for use in diet health education. British Journal Of Nutrition. 66(1). 3–15. 30 indexed citations
12.
Miczek, Klaus A. & M O'Donnell. (1980). Alcohol and chlordiazepoxide increase suppressed aggression in mice. Psychopharmacology. 69(1). 39–44. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026